Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6XSL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $98,899
Award facts
- Contract value 100% obligated
- $98,898.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $98.9M on September 8, 2025, for the supply of Entyvio 300 mg vials. This delivery order, which carries an ultimate completion date of September 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of the company's substantial role as a critical pharmaceutical supplier to the Department of Defense healthcare system.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $500M through November 2026, which enables the agency to procure a comprehensive portfolio of pharmaceutical products to support military health facilities worldwide. The company's contract portfolio demonstrates consistent success in supplying branded and generic prescription medications, biologics, and medical consumables to federal healthcare systems. Entyvio, a biologic pharmaceutical product, aligns with the company's established track record of delivering specialty medications and injectable treatments to support Department of Defense medical supply requirements.
Quick answers
Who was awarded contract SPE2DX25F6XSL?
SPE2DX25F6XSL was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 8, 2025.
How much is contract SPE2DX25F6XSL worth?
The government has obligated $98,899 on SPE2DX25F6XSL.
Is contract SPE2DX25F6XSL an order under another contract?
Yes. SPE2DX25F6XSL is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XSL competed?
The extent of competition for SPE2DX25F6XSL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award